Abstract
Inherited bone marrow failure syndromes are disorders of hematopoiesis that are mostly encountered in childhood. Taking the basisfrom genetics, they are characterized by pancytopenia, increased risk of developing myelodysplastic syndrome and malignancy.Extrahematopoietic presentations are observed often in addition to symptoms related to defective hematopoiesis (also known asbone marrow failure). The biology, clinical features, and management of the main syndromes such as Fanconi anemia, dyskeratosiscongenita, Shwachman-Diamond syndrome, congenital amegakaryocytic thrombocytopenia, Diamond-Blackfan anemia, andsevere congenital neutropenia are briefly summarized in this review.
Reference37 articles.
1. 1. Gök V, Erdem Ş, Haliloğlu Y, et al. Immunodeficiency associated with a novel functionally defective variant of SLC19A1 benefits from folinic acid treatment. Genes Immun. 2023;24:12-20. [Crossref]
2. 2. Shakila K, Myers KC, Newburger P (ed), Negrin RS (ed), Rosmarin AG (ed). Hematopoietic cell transplantation (HCT) for inherited bone marrow failure syndromes (IBMFS). In: UpToDate.; 2021. Accessed March 15, 2023. [Crossref]
3. 3. Fiesco-Roa MÓ, García-de Teresa B, Leal-Anaya P, et al. Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability. Front Oncol. 2022;12:949435. [Crossref]
4. 4. Green AM, Kupfer GM. Fanconi Anemia. Hematol Oncol Clin North Am. 2009;23:193-214. [Crossref]
5. 5. Park M. Overview of inherited bone marrow failure syndromes. Blood Res. 2022;57(Suppl 1):49-54. [Crossref]